Minoru Miyashita

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Breast cancer research and treatment

Cancers

International journal of molecular sciences

Breast cancer (Tokyo, Japan)

This page only lists publications with an associated author ORCID identifier.

Publications

Saki Nakagawa, Minoru Miyashita, Ichiro Maeda, Atsushi Goda, Hiroshi Tada, Masakazu Amari, Yasuyuki Kojima, Koichiro Tsugawa, Yasuyo Ohi, Yasuaki Sagara, Miku Sato, Akiko Ebata, Narumi Harada-Shoji, Takashi Suzuki, Makoto Nakanishi, Tomohiko Ohta, Takanori Ishida
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Breast cancer research and treatment 204 (3) (2024)
Saki Nakagawa, Minoru Miyashita, Ichiro Maeda, Atsushi Goda, Hiroshi Tada, Masakazu Amari, Yasuyuki Kojima, Koichiro Tsugawa, Yasuyo Ohi, Yasuaki Sagara, Miku Sato, Akiko Ebata, Narumi Harada-Shoji, Takashi Suzuki, Makoto Nakanishi, Tomohiko Ohta, Takanori Ishida
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Breast cancer research and treatment 204 (3) (2024)
Saki Nakagawa, Minoru Miyashita, Ichiro Maeda, Atsushi Goda, Hiroshi Tada, Masakazu Amari, Yasuyuki Kojima, Koichiro Tsugawa, Yasuyo Ohi, Yasuaki Sagara, Miku Sato, Akiko Ebata, Narumi Harada-Shoji, Takashi Suzuki, Makoto Nakanishi, Tomohiko Ohta, Takanori Ishida
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Breast cancer research and treatment (2024)
Saki Nakagawa, Minoru Miyashita, Ichiro Maeda, Atsushi Goda, Hiroshi Tada, Masakazu Amari, Yasuyuki Kojima, Koichiro Tsugawa, Yasuyo Ohi, Yasuaki Sagara, Miku Sato, Akiko Ebata, Narumi Harada-Shoji, Takashi Suzuki, Makoto Nakanishi, Tomohiko Ohta, Takanori Ishida
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Breast cancer research and treatment 204 (3) (2024)
Mio Yamaguchi, Kiyoshi Takagi, Yasuhiro Miki, Ai Sato, Erina Iwabuchi, Minoru Miyashita, Takashi Suzuki
The Pro-Tumorigenic Role of Chemotherapy-Induced Extracellular HSP70 from Breast Cancer Cells via Intratumoral Macrophages. Cancers 15 (6) (2023)
Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji
Annual report of the Japanese Breast Cancer Registry for 2019. Breast cancer (Tokyo, Japan) (2023)
Mio Yamaguchi, Kiyoshi Takagi, Yasuhiro Miki, Ai Sato, Erina Iwabuchi, Minoru Miyashita, Takashi Suzuki
The Pro-Tumorigenic Role of Chemotherapy-Induced Extracellular HSP70 from Breast Cancer Cells via Intratumoral Macrophages. Cancers 15 (6) (2023)
Ai Sato, Kiyoshi Takagi, Ayano Yoshimura, Wakana Tsukamoto, Mio Yamaguchi, Yasuhiro Miki, Akiko Ebata, Minoru Miyashita, Takashi Suzuki
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker. International journal of molecular sciences 24 (9) (2023)
Ai Sato, Kiyoshi Takagi, Ayano Yoshimura, Wakana Tsukamoto, Mio Yamaguchi, Yasuhiro Miki, Akiko Ebata, Minoru Miyashita, Takashi Suzuki
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker. International journal of molecular sciences 24 (9) (2023)
Haruhiko Shindo, Narumi Harada-Shoji, Akiko Ebata, Miku Sato, Tomoyoshi Soga, Minoru Miyashita, Hiroshi Tada, Masaaki Kawai, Shinkichi Kosaka, Koji Onuki, Shin Usami, Shozo Furumoto, Shinichi Hayashi, Takaaki Abe, Takashi Suzuki, Takanori Ishida, Hironobu Sasano
Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer. Cancers 13 (17) (2021)
Mio Yamaguchi, Kiyoshi Takagi, Koki Narita, Yasuhiro Miki, Yoshiaki Onodera, Minoru Miyashita, Hironobu Sasano, Takashi Suzuki
Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells. International journal of molecular sciences 22 (4) (2021)
Minoru Miyashita, Masaya Hattori, Toshimi Takano, Tatsuya Toyama, Hiroji Iwata
Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials. Breast cancer (Tokyo, Japan) 27 (3) (2020)

Minoru Miyashita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Minoru Miyashita